Trials / Unknown
UnknownNCT00488176
Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis
Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation Measured by Exhaled Nitric Oxide Concentration in Children With Seasonal Allergic Rhinitis
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 116 (estimated)
- Sponsor
- Medical University of Lodz · Academic / Other
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to compare the effect of montelukast and cetirizine on allergic inflammation measured by exhaled nitric oxide concentration in children with seasonal allergic rhinitis.
Detailed description
During the pollen season children with seasonal allergic rhinitis without concomitant asthma are at risk of having allergic inflammation in the lower respiratory tract. About 60% of children with seasonal allergic rhinitis present bronchial hyperresponsiveness and signs and symptoms of asthma. The aim of this study is to compare the effect of montelukast and cetirizine on allergic inflammation measured by exhaled nitric oxide concentration in children with seasonal allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | montelukast | montelukast sodium |
| DRUG | cetirizine | cetirizine |
| DRUG | montelukast and cetirizine | montelukast and cetirizine |
| DRUG | placebo | placebo |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2013-11-01
- Completion
- 2013-12-01
- First posted
- 2007-06-20
- Last updated
- 2013-02-07
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT00488176. Inclusion in this directory is not an endorsement.